Skip to content

Using Apollo Neuro in Autistic Children With Self-Injurious Behavior

Feasibility and Usability of the Apollo Neuro, a Wearable Sensory Device, in Autistic Children With Self-Injurious Behavior

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07648420
Enrollment
18
Registered
2026-06-15
Start date
2026-12-01
Completion date
2027-11-01
Last updated
2026-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder, Self-Injurious Behavior

Keywords

Apollo Neuro Device, Sensory Responsivity, Autonomic Regulation, Wearable Device, Vibrotactile Stimulation

Brief summary

This study will evaluate the feasibility and acceptability of the Apollo Neuro, a wearable vibrotactile sensory device, in autistic children who engage in self-injurious behavior (SIB). Participants will wear the device for at least 3 hours per day over a 30-35 day period with caregiver support. Outcomes will include adherence to device use, caregiver-reported feasibility and acceptability, and descriptive characterization of caregiver-reported self- injurious and repetitive behaviors during the study period. This preliminary, single-group study is not designed to evaluate efficacy and will inform the design of future controlled trials.

Detailed description

who engage in self-injurious behavior (SIB). Participants will wear the device for at least 3 hours per day over a 30-35 day period with caregiver support. Outcomes will include adherence to device use, caregiver-reported feasibility and acceptability, and descriptive characterization of caregiver-reported self-injurious and repetitive behaviors during the study period. This preliminary, single-group study is not designed to evaluate efficacy and will inform the design of future controlled trials.

Interventions

Child participants will wear the activated device for a minimum of three hours per day on at least 30 of 35 consecutive days, consistent with the study protocol. The device is worn externally (e.g., wrist, ankle, or waist) and delivers low intensity vibrations through intact skin.

Sponsors

Virginia Commonwealth University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Intervention model description

Feasibility, Quasi-experimental, within subject, pre- and post-test design

Eligibility

Sex/Gender
ALL
Age
6 Years to 179 Months
Healthy volunteers
No

Inclusion criteria

for child: * Diagnosis of autism spectrum disorder (ASD), as reported by caregiver * Presence of self-injurious behavior, as reported by caregiver * Demonstrates sensory over and/or under- responsivity * Aged 6 years to 14 years, 11 months (179 months) at the time of enrollment * Has a caregiver willing and able to provide consent and participate in study procedures

Exclusion criteria

for child: * Has medical condition that may increase risk with use of a wearable nibrotactile device, including: * implanted medical or neurological devices (e.g., pacemaker) * significant cardiac conditions or arrhythmias * history of syncope (fainting) * Known seizure disorder without physician clearance * Regular use of nibrotactile or autonomic- modulating wearable devices within the past 90 days * Any condition that, in the judgment of the investigator, would interfere with safe participation or interpretation of study procedures Inclusion Criteria for Caregiver: * Parent or legal guardian of the enrolled child participant * Able to provide informed consent in English * Able and willing to support device use according to study protocol and complete study-related data collection * Has access to a smartphone or compatible device capable of operating the Apollo Neuro application for the duration of study period

Design outcomes

Primary

MeasureTime frameDescription
Adherence to wearing the Apollo Neuro Wearable30-35 daysCaregiver-reported acceptability of the intervention, as measured by the Acceptability of Intervention Measure (AIM), a validated 4-item instrument assessing the perceived agreeableness, satisfaction, and usability of the intervention. Each item is rated on a 5-point Likert scale ranging from 1 (Completely disagree) to 5 (Completely agree). Responses will be summarized descriptively using mean scores and response distributions.
Acceptability of Intervention Measure (AIM)30-35 daysCaregiver-reported acceptability of the intervention, as measured by the Acceptability of Intervention Measure (AIM), a validated 4-item instrument assessing the perceived agreeableness, satisfaction, and usability of the intervention. Each item is rated on a 5-point Likert scale ranging from 1 (Completely disagree) to 5 (Completely agree). Responses will be summarized descriptively using mean scores and response distributions.
Feasibility of Intervention Measure (FIM)30-35 daysCaregiver-reported feasibility of the intervention, as measured by the Feasibility of Intervention Measure (FIM), a validated 4-item instrument assessing the extent to which the intervention can be successfully implemented within the home setting. Each item is rated on a 5-point Likert scale ranging from 1(Completely disagree) to 5 (Completely agree). Responses will be summarized descriptively using mean scores and response distributions.
The Repetitive Behavior Scale-Revised (RBS-R)30-35 daysCaregiver-reported behaviors, as measured by the Repetitive Behavior Scale-Revised (RBS-R), a validated 43-item questionnaire assessing the presence and severity of restricted and repetitive behaviors in individuals with autism spectrum disorder, including self-injurious behavior. The measure is completed by caregivers at baseline and post-intervention using a 4-point Likert scale. Scores will be summarized descriptively to characterize patterns over the study period.
Change in intensity of self-injurious behavior30-35 daysChanges in the intensity of self-injurious behavior associated with the use of the Apollo Neuro wearable device will be measured by caregiver-reported tracking daily ratings of peak self-injurious behavior intensity on a study designed form tracking the participant adherence.
Changes in caregiver-reported SIB intensity30-35 daysDaily caregiver-reported ratings of peak self-injurious behavior intensity, measured using a visual analog scale (VAS) recorded on a study-designed data collection form. Caregivers will provide ratings each day throughout the intervention period. Data will be summarized descriptively to characterize variability and patterns over time.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORStacey Reynolds

Virginia Commonwealth University

CONTACTLaura Lee Robins
robinslp@vcu.edu(757) 285-3486

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 18, 2026